Ali, Shadan <br/><br/>
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.  [electronic resource] 

 -  Cancer research  May 2010 
 - 3606-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Retracted Publication 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-09-4598  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Curcumin--administration & dosage<br/>DNA, Complementary--genetics<br/>DNA, Neoplasm--genetics<br/>Deoxycytidine--administration & dosage<br/>Dinoprostone--antagonists & inhibitors<br/>Drug Synergism<br/>Gene Expression Regulation, Neoplastic--genetics<br/>Gene Silencing<br/>Humans<br/>MicroRNAs--biosynthesis<br/>NF-kappa B--antagonists & inhibitors<br/>Oligonucleotides, Antisense--genetics<br/>PTEN Phosphohydrolase--genetics<br/>Pancreatic Neoplasms--drug therapy<br/>Transfection<br/>Triterpenes--administration & dosage<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Gemcitabine